G-BA decisions 1 February 2024
Here are the G-BA decisions from the G-BA meeting held on 1 February 2024 on the early benefit assessments of Camzyos, Sirturo,
Category: News and updates
G-BA decisions from 21 December 2023
Here are the G-BA decisions from the G-BA meeting held on 21 December 2023 on the early benefit assessments of Yescarta, Bimzelx,
G-BA decisions from 7 Dec 2023
Here are the G-BA decisions from the G-BA meeting held on 7 December 2023 on the early benefit assessments of Entresto, Cosentyx,
G-BA decisions from 16 November 2023
Here are the G-BA decisions from the G-BA meeting held on 16 November 2023 on the early benefit assessments of Breyanzi and
G-BA decisions from 2 November 2023
Here are the G-BA decisions from the G-BA meeting held on 2 November 2023 on the early benefit assessments of Zynlonta, Imcivree,
IQWiG Methods in German Benefit Assessments: Version 7.0 Now in Force
Introduction The Institute for Quality and Efficiency in Health Care (IQWiG), in its pursuit of promoting evidence-based healthcare decisions, continuously refines its
G-BA decisions from 19 October 2023
Here are the G-BA decisions from the G-BA meeting held on 19 October 2023 on the early benefit assessments of Hemgenix, Libtayo,
G-BA decisions from 5 October 2023
Here are the G-BA decisions from the G-BA meeting held on 5 October 2023 on the early benefit assessments of Imfinzi, Imjudo,
G-BA decisions from 21 September 2023
Here are the G-BA decisions from the G-BA meeting held on 21 September 2023 on the early benefit assessments of Nubeqa, Spravato,
G-BA decisions from 17 August 2023
Here are the G-BA decisions from the G-BA meeting held on 17 August 2023 on the early benefit assessments of Carvykti, Hemlibra,